BRIEF-Kazia Therapeutics Announces Transformative Preclinical Data

Reuters
Jun 11
BRIEF-<a href="https://laohu8.com/S/KZA.AU">Kazia Therapeutics</a> Announces Transformative Preclinical Data

June 11 (Reuters) - Kazia Therapeutics Ltd KZIA.O:

  • KAZIA THERAPEUTICS ANNOUNCES TRANSFORMATIVE PRECLINICAL DATA DEMONSTRATING PAXALISIB'S POTENTIAL TO OVERCOME IMMUNOTHERAPY RESISTANCE IN TRIPLE-NEGATIVE BREAST CANCER (TNBC)

Source text: ID:nPn60mKLsa

Further company coverage: KZIA.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10